BioNTech shares surge as vaccine-maker's profits soar on booming outlook

HEALTH-CORONAVIRUS/FOSUN-TAIWAN

German pharmaceutical maker BioNTech, which developed the first widely used coronavirus vaccine with Pfizer, swung to a huge profit in the second quarter on record sales.



from CBC | Health News https://ift.tt/3jBVOVV

Aucun commentaire:

Enregistrer un commentaire